(Q48408264)

English

Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure.

scientific article published on 16 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

0 references

author name string

Christoph Birner

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Coskun Ulucan

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Mona Bratfisch

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Tobias Götz

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Alexander Dietl

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Frank Schweda

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Günter A Riegger

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Andreas Luchner

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

publication date

16 August 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

385

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

1117-1125

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

https://scigraph.springernature.com/pub.10.1007/s00210-012-0791-6

0 references

A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Combined neutral endopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Experimental heart failure produced by rapid ventricular pacing in the dog.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Angiotensin II in the evolution of experimental heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

The natriuretic peptides in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Effect of neutral endopeptidase inhibitor in rats with congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition for blood pressure control: emerging experience

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition: effective blood pressure control for vascular protection

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Cytokines--causes, players or bystanders in heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and clinical relevance of animal models of heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic effect of combined treatment with omapatrilat and adrenomedullin on the progression of heart failure in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00210-012-0791-6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48408264&oldid=1414712015"